SCYNEXIS, Inc. (SCYX): Price and Financial Metrics
SCYX Price/Volume Stats
| Current price | $0.92 | 52-week high | $2.31 |
| Prev. close | $0.89 | 52-week low | $0.72 |
| Day low | $0.86 | Volume | 61,400 |
| Day high | $0.92 | Avg. volume | 166,091 |
| 50-day MA | $0.91 | Dividend yield | N/A |
| 200-day MA | $1.17 | Market Cap | 35.82M |
SCYX Stock Price Chart Interactive Chart >
SCYNEXIS, Inc. (SCYX) Company Bio
SCYNEXIS, Inc., a pharmaceutical company, develops and commercializes novel anti-infectives to address unmet therapeutic needs. Its lead product candidate includes SCY-078, which is in Phase I clinical trials of the intravenous formulation; Phase II clinical trials for the treatment of invasive candida infections; and Phase II clinical trials for unmet medical needs, such as vulvovaginal candidiasis. The company was founded in 1999 and is based in Jersey City, New Jersey.
SCYX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SCYX Price Returns
| 1-mo | -3.90% |
| 3-mo | -4.93% |
| 6-mo | -25.20% |
| 1-year | -58.56% |
| 3-year | -56.40% |
| 5-year | -89.62% |
| YTD | -23.97% |
| 2024 | -45.74% |
| 2023 | 42.95% |
| 2022 | -74.43% |
| 2021 | -20.26% |
| 2020 | -15.93% |